These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 18507014)

  • 1. Novel link between estrogen receptor alpha and hedgehog pathway in breast cancer.
    Koga K; Nakamura M; Nakashima H; Akiyoshi T; Kubo M; Sato N; Kuroki S; Nomura M; Tanaka M; Katano M
    Anticancer Res; 2008; 28(2A):731-40. PubMed ID: 18507014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oestrogen receptor-alpha contributes to the regulation of the hedgehog signalling pathway in ERalpha-positive gastric cancer.
    Kameda C; Nakamura M; Tanaka H; Yamasaki A; Kubo M; Tanaka M; Onishi H; Katano M
    Br J Cancer; 2010 Feb; 102(4):738-47. PubMed ID: 20087349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Hedgehog pathway is a possible therapeutic target for patients with estrogen receptor-negative breast cancer.
    Kameda C; Tanaka H; Yamasaki A; Nakamura M; Koga K; Sato N; Kubo M; Kuroki S; Tanaka M; Katano M
    Anticancer Res; 2009 Mar; 29(3):871-9. PubMed ID: 19414322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination of cyclopamine and tamoxifen promotes survival and migration of mcf-7 breast cancer cells--interaction of hedgehog-gli and estrogen receptor signaling pathways.
    Sabol M; Trnski D; Uzarevic Z; Ozretic P; Musani V; Rafaj M; Cindric M; Levanat S
    PLoS One; 2014; 9(12):e114510. PubMed ID: 25503972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blockade of the Hedgehog pathway downregulates estrogen receptor alpha signaling in breast cancer cells.
    Diao Y; Azatyan A; Rahman MF; Zhao C; Zhu J; Dahlman-Wright K; Zaphiropoulos PG
    Oncotarget; 2016 Nov; 7(44):71580-71593. PubMed ID: 27689403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oestrogen receptor-alpha regulates non-canonical Hedgehog-signalling in the mammary gland.
    Okolowsky N; Furth PA; Hamel PA
    Dev Biol; 2014 Jul; 391(2):219-29. PubMed ID: 24769368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hedgehog Acyltransferase as a target in estrogen receptor positive, HER2 amplified, and tamoxifen resistant breast cancer cells.
    Matevossian A; Resh MD
    Mol Cancer; 2015 Apr; 14():72. PubMed ID: 25889650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nuclear factor-kappaB contributes to hedgehog signaling pathway activation through sonic hedgehog induction in pancreatic cancer.
    Nakashima H; Nakamura M; Yamaguchi H; Yamanaka N; Akiyoshi T; Koga K; Yamaguchi K; Tsuneyoshi M; Tanaka M; Katano M
    Cancer Res; 2006 Jul; 66(14):7041-9. PubMed ID: 16849549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The NEDD8 pathway is required for proteasome-mediated degradation of human estrogen receptor (ER)-alpha and essential for the antiproliferative activity of ICI 182,780 in ERalpha-positive breast cancer cells.
    Fan M; Bigsby RM; Nephew KP
    Mol Endocrinol; 2003 Mar; 17(3):356-65. PubMed ID: 12554766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen Enhances the Cell Viability and Motility of Breast Cancer Cells through the ERα-ΔNp63-Integrin β4 Signaling Pathway.
    Ho JY; Chang FW; Huang FS; Liu JM; Liu YP; Chen SP; Liu YL; Cheng KC; Yu CP; Hsu RJ
    PLoS One; 2016; 11(2):e0148301. PubMed ID: 26845172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro and in vivo inhibition of breast cancer cell growth by targeting the Hedgehog/GLI pathway with SMO (GDC-0449) or GLI (GANT-61) inhibitors.
    Benvenuto M; Masuelli L; De Smaele E; Fantini M; Mattera R; Cucchi D; Bonanno E; Di Stefano E; Frajese GV; Orlandi A; Screpanti I; Gulino A; Modesti A; Bei R
    Oncotarget; 2016 Feb; 7(8):9250-70. PubMed ID: 26843616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p53-Independent negative regulation of p21/cyclin-dependent kinase-interacting protein 1 by the sonic hedgehog-glioma-associated oncogene 1 pathway in gastric carcinoma cells.
    Ohta M; Tateishi K; Kanai F; Watabe H; Kondo S; Guleng B; Tanaka Y; Asaoka Y; Jazag A; Imamura J; Ijichi H; Ikenoue T; Sata M; Miyagishi M; Taira K; Tada M; Kawabe T; Omata M
    Cancer Res; 2005 Dec; 65(23):10822-9. PubMed ID: 16322228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. P2Y2 receptor-mediated modulation of estrogen-induced proliferation of breast cancer cells.
    Li HJ; Wang LY; Qu HN; Yu LH; Burnstock G; Ni X; Xu M; Ma B
    Mol Cell Endocrinol; 2011 May; 338(1-2):28-37. PubMed ID: 21356271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased vascularity and spontaneous metastasis of breast cancer by hedgehog signaling mediated upregulation of cyr61.
    Harris LG; Pannell LK; Singh S; Samant RS; Shevde LA
    Oncogene; 2012 Jul; 31(28):3370-80. PubMed ID: 22056874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic silencing of sonic hedgehog elicits antitumor immune response and suppresses tumor growth by inhibiting the hedgehog signaling pathway in metastatic spine tumors in Sprague-Dawley rats.
    Shi G; Zhang H; Yu Q; Jin H; Hu CM; Li SC; Ji YB
    J Cell Biochem; 2018 Nov; 119(11):9591-9603. PubMed ID: 30191602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of estrogen receptor α-36 expression by bone morphogenetic protein 2 in breast cancer cell lines.
    Wang D; Huang P; Zhu B; Sun L; Huang Q; Wang J
    Mol Med Rep; 2012 Sep; 6(3):591-6. PubMed ID: 22711074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. KMT2C mediates the estrogen dependence of breast cancer through regulation of ERα enhancer function.
    Gala K; Li Q; Sinha A; Razavi P; Dorso M; Sanchez-Vega F; Chung YR; Hendrickson R; Hsieh JJ; Berger M; Schultz N; Pastore A; Abdel-Wahab O; Chandarlapaty S
    Oncogene; 2018 Aug; 37(34):4692-4710. PubMed ID: 29755131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of estrogen receptor alpha protein level and survival function by DBC-1.
    Trauernicht AM; Kim SJ; Kim NH; Boyer TG
    Mol Endocrinol; 2007 Jul; 21(7):1526-36. PubMed ID: 17473282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pentagalloylglucose inhibits estrogen receptor alpha by lysosome-dependent depletion and modulates ErbB/PI3K/Akt pathway in human breast cancer MCF-7 cells.
    Hua KT; Way TD; Lin JK
    Mol Carcinog; 2006 Aug; 45(8):551-60. PubMed ID: 16637063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TFAP2C controls hormone response in breast cancer cells through multiple pathways of estrogen signaling.
    Woodfield GW; Horan AD; Chen Y; Weigel RJ
    Cancer Res; 2007 Sep; 67(18):8439-43. PubMed ID: 17875680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.